UK Markets open in 48 mins

Global Topical Drug Delivery Market to Reach $147.1 Billion by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Topical Drug Delivery estimated at US$101. 3 Billion in the year 2020, is projected to reach a revised size of US$147. 1 Billion by 2027, growing at a CAGR of 5.

New York, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Topical Drug Delivery Industry" - https://www.reportlinker.com/p06033143/?utm_source=GNW
5% over the analysis period 2020-2027. Semi-Solid Formulations, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$57.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Liquid Formulations segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $29.6 Billion, While China is Forecast to Grow at 5.1% CAGR

The Topical Drug Delivery market in the U.S. is estimated at US$29.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$26 Billion by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Solid Formulations Segment to Record 4.8% CAGR

In the global Solid Formulations segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$15.5 Billion in the year 2020 will reach a projected size of US$21.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 43 Featured) -
3M
Acrux Limited
Bayer AG
Biofarmitalia s.r.l
Cipla Inc.
Crescita Therapeutics Inc.
Galderma S.A.
GlaxoSmithKline plc
Janssen Global Services, LLC
Lohmann Therapie-Systeme AG
Medpharm
Mylan N.V.
Nitto Denko Corporation
Novartis AG
Pharmatek Laboratories, Inc.
Pocono Coated Products LLC
Skinvisible Pharmaceuticals, Inc.
Stiefel Laboratories, Inc.
Tapemark
Valeant Pharmaceuticals International, Inc.
West Pharmaceutical Services, Inc.


Read the full report: https://www.reportlinker.com/p06033143/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Topical Drug Delivery - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Topical Drug Delivery by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Topical Drug Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Topical Drug Delivery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Semi-Solid Formulations by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Semi-Solid Formulations by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Semi-Solid Formulations
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Liquid Formulations by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Liquid Formulations by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Liquid Formulations by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Solid Formulations by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Solid Formulations by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Solid Formulations by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Transdermal Products by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Transdermal Products by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Transdermal Products by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for Home
Care Settings by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Home Care Settings by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Home Care Settings by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Hospitals & Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for Burn
Centers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 23: World Historic Review for Burn Centers by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Burn Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Dermal Drug Delivery by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 29: World Historic Review for Dermal Drug Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 30: World 15-Year Perspective for Dermal Drug Delivery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 31: World Recent Past, Current & Future Analysis for
Nasal Drug Delivery by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Nasal Drug Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Nasal Drug Delivery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 34: World Recent Past, Current & Future Analysis for
Ophthalmic Drug Delivery by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 35: World Historic Review for Ophthalmic Drug Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 36: World 15-Year Perspective for Ophthalmic Drug
Delivery by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2021 & 2027

Table 37: World Recent Past, Current & Future Analysis for
Rectal Drug Delivery by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 38: World Historic Review for Rectal Drug Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 39: World 15-Year Perspective for Rectal Drug Delivery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 40: World Recent Past, Current & Future Analysis for
Vaginal Drug Delivery by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 41: World Historic Review for Vaginal Drug Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 42: World 15-Year Perspective for Vaginal Drug Delivery
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 43: World Topical Drug Delivery Market Analysis of Annual
Sales in US$ Million for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Topical Drug Delivery Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 44: USA Recent Past, Current & Future Analysis for
Topical Drug Delivery by Product - Semi-Solid Formulations,
Liquid Formulations, Solid Formulations and Transdermal
Products - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 45: USA Historic Review for Topical Drug Delivery by
Product - Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 46: USA 15-Year Perspective for Topical Drug Delivery by
Product - Percentage Breakdown of Value Sales for Semi-Solid
Formulations, Liquid Formulations, Solid Formulations and
Transdermal Products for the Years 2012, 2021 & 2027

Table 47: USA Recent Past, Current & Future Analysis for
Topical Drug Delivery by End-Use - Home Care Settings,
Hospitals & Clinics, Burn Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 48: USA Historic Review for Topical Drug Delivery by
End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 49: USA 15-Year Perspective for Topical Drug Delivery by
End-Use - Percentage Breakdown of Value Sales for Home Care
Settings, Hospitals & Clinics, Burn Centers and Other End-Uses
for the Years 2012, 2021 & 2027

Table 50: USA Recent Past, Current & Future Analysis for
Topical Drug Delivery by Route Of Administration - Dermal Drug
Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal
Drug Delivery and Vaginal Drug Delivery - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 51: USA Historic Review for Topical Drug Delivery by
Route Of Administration - Dermal Drug Delivery, Nasal Drug
Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and
Vaginal Drug Delivery Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 52: USA 15-Year Perspective for Topical Drug Delivery by
Route Of Administration - Percentage Breakdown of Value Sales
for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug
Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for
the Years 2012, 2021 & 2027

CANADA
Table 53: Canada Recent Past, Current & Future Analysis for
Topical Drug Delivery by Product - Semi-Solid Formulations,
Liquid Formulations, Solid Formulations and Transdermal
Products - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 54: Canada Historic Review for Topical Drug Delivery by
Product - Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 55: Canada 15-Year Perspective for Topical Drug Delivery
by Product - Percentage Breakdown of Value Sales for Semi-Solid
Formulations, Liquid Formulations, Solid Formulations and
Transdermal Products for the Years 2012, 2021 & 2027

Table 56: Canada Recent Past, Current & Future Analysis for
Topical Drug Delivery by End-Use - Home Care Settings,
Hospitals & Clinics, Burn Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 57: Canada Historic Review for Topical Drug Delivery by
End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 58: Canada 15-Year Perspective for Topical Drug Delivery
by End-Use - Percentage Breakdown of Value Sales for Home Care
Settings, Hospitals & Clinics, Burn Centers and Other End-Uses
for the Years 2012, 2021 & 2027

Table 59: Canada Recent Past, Current & Future Analysis for
Topical Drug Delivery by Route Of Administration - Dermal Drug
Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal
Drug Delivery and Vaginal Drug Delivery - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 60: Canada Historic Review for Topical Drug Delivery by
Route Of Administration - Dermal Drug Delivery, Nasal Drug
Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and
Vaginal Drug Delivery Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 61: Canada 15-Year Perspective for Topical Drug Delivery
by Route Of Administration - Percentage Breakdown of Value
Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic
Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery
for the Years 2012, 2021 & 2027

JAPAN
Topical Drug Delivery Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 62: Japan Recent Past, Current & Future Analysis for
Topical Drug Delivery by Product - Semi-Solid Formulations,
Liquid Formulations, Solid Formulations and Transdermal
Products - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 63: Japan Historic Review for Topical Drug Delivery by
Product - Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 64: Japan 15-Year Perspective for Topical Drug Delivery
by Product - Percentage Breakdown of Value Sales for Semi-Solid
Formulations, Liquid Formulations, Solid Formulations and
Transdermal Products for the Years 2012, 2021 & 2027

Table 65: Japan Recent Past, Current & Future Analysis for
Topical Drug Delivery by End-Use - Home Care Settings,
Hospitals & Clinics, Burn Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 66: Japan Historic Review for Topical Drug Delivery by
End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 67: Japan 15-Year Perspective for Topical Drug Delivery
by End-Use - Percentage Breakdown of Value Sales for Home Care
Settings, Hospitals & Clinics, Burn Centers and Other End-Uses
for the Years 2012, 2021 & 2027

Table 68: Japan Recent Past, Current & Future Analysis for
Topical Drug Delivery by Route Of Administration - Dermal Drug
Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal
Drug Delivery and Vaginal Drug Delivery - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 69: Japan Historic Review for Topical Drug Delivery by
Route Of Administration - Dermal Drug Delivery, Nasal Drug
Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and
Vaginal Drug Delivery Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 70: Japan 15-Year Perspective for Topical Drug Delivery
by Route Of Administration - Percentage Breakdown of Value
Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic
Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery
for the Years 2012, 2021 & 2027

CHINA
Topical Drug Delivery Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 71: China Recent Past, Current & Future Analysis for
Topical Drug Delivery by Product - Semi-Solid Formulations,
Liquid Formulations, Solid Formulations and Transdermal
Products - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 72: China Historic Review for Topical Drug Delivery by
Product - Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 73: China 15-Year Perspective for Topical Drug Delivery
by Product - Percentage Breakdown of Value Sales for Semi-Solid
Formulations, Liquid Formulations, Solid Formulations and
Transdermal Products for the Years 2012, 2021 & 2027

Table 74: China Recent Past, Current & Future Analysis for
Topical Drug Delivery by End-Use - Home Care Settings,
Hospitals & Clinics, Burn Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 75: China Historic Review for Topical Drug Delivery by
End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 76: China 15-Year Perspective for Topical Drug Delivery
by End-Use - Percentage Breakdown of Value Sales for Home Care
Settings, Hospitals & Clinics, Burn Centers and Other End-Uses
for the Years 2012, 2021 & 2027

Table 77: China Recent Past, Current & Future Analysis for
Topical Drug Delivery by Route Of Administration - Dermal Drug
Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal
Drug Delivery and Vaginal Drug Delivery - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 78: China Historic Review for Topical Drug Delivery by
Route Of Administration - Dermal Drug Delivery, Nasal Drug
Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and
Vaginal Drug Delivery Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 79: China 15-Year Perspective for Topical Drug Delivery
by Route Of Administration - Percentage Breakdown of Value
Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic
Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery
for the Years 2012, 2021 & 2027

EUROPE
Topical Drug Delivery Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 80: Europe Recent Past, Current & Future Analysis for
Topical Drug Delivery by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 81: Europe Historic Review for Topical Drug Delivery by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 82: Europe 15-Year Perspective for Topical Drug Delivery
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2021 & 2027

Table 83: Europe Recent Past, Current & Future Analysis for
Topical Drug Delivery by Product - Semi-Solid Formulations,
Liquid Formulations, Solid Formulations and Transdermal
Products - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 84: Europe Historic Review for Topical Drug Delivery by
Product - Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 85: Europe 15-Year Perspective for Topical Drug Delivery
by Product - Percentage Breakdown of Value Sales for Semi-Solid
Formulations, Liquid Formulations, Solid Formulations and
Transdermal Products for the Years 2012, 2021 & 2027

Table 86: Europe Recent Past, Current & Future Analysis for
Topical Drug Delivery by End-Use - Home Care Settings,
Hospitals & Clinics, Burn Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 87: Europe Historic Review for Topical Drug Delivery by
End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 88: Europe 15-Year Perspective for Topical Drug Delivery
by End-Use - Percentage Breakdown of Value Sales for Home Care
Settings, Hospitals & Clinics, Burn Centers and Other End-Uses
for the Years 2012, 2021 & 2027

Table 89: Europe Recent Past, Current & Future Analysis for
Topical Drug Delivery by Route Of Administration - Dermal Drug
Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal
Drug Delivery and Vaginal Drug Delivery - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 90: Europe Historic Review for Topical Drug Delivery by
Route Of Administration - Dermal Drug Delivery, Nasal Drug
Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and
Vaginal Drug Delivery Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 91: Europe 15-Year Perspective for Topical Drug Delivery
by Route Of Administration - Percentage Breakdown of Value
Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic
Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery
for the Years 2012, 2021 & 2027

FRANCE
Topical Drug Delivery Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 92: France Recent Past, Current & Future Analysis for
Topical Drug Delivery by Product - Semi-Solid Formulations,
Liquid Formulations, Solid Formulations and Transdermal
Products - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 93: France Historic Review for Topical Drug Delivery by
Product - Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 94: France 15-Year Perspective for Topical Drug Delivery
by Product - Percentage Breakdown of Value Sales for Semi-Solid
Formulations, Liquid Formulations, Solid Formulations and
Transdermal Products for the Years 2012, 2021 & 2027

Table 95: France Recent Past, Current & Future Analysis for
Topical Drug Delivery by End-Use - Home Care Settings,
Hospitals & Clinics, Burn Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 96: France Historic Review for Topical Drug Delivery by
End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 97: France 15-Year Perspective for Topical Drug Delivery
by End-Use - Percentage Breakdown of Value Sales for Home Care
Settings, Hospitals & Clinics, Burn Centers and Other End-Uses
for the Years 2012, 2021 & 2027

Table 98: France Recent Past, Current & Future Analysis for
Topical Drug Delivery by Route Of Administration - Dermal Drug
Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal
Drug Delivery and Vaginal Drug Delivery - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 99: France Historic Review for Topical Drug Delivery by
Route Of Administration - Dermal Drug Delivery, Nasal Drug
Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and
Vaginal Drug Delivery Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 100: France 15-Year Perspective for Topical Drug Delivery
by Route Of Administration - Percentage Breakdown of Value
Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic
Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery
for the Years 2012, 2021 & 2027

GERMANY
Topical Drug Delivery Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 101: Germany Recent Past, Current & Future Analysis for
Topical Drug Delivery by Product - Semi-Solid Formulations,
Liquid Formulations, Solid Formulations and Transdermal
Products - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 102: Germany Historic Review for Topical Drug Delivery by
Product - Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 103: Germany 15-Year Perspective for Topical Drug
Delivery by Product - Percentage Breakdown of Value Sales for
Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products for the Years 2012, 2021 &
2027

Table 104: Germany Recent Past, Current & Future Analysis for
Topical Drug Delivery by End-Use - Home Care Settings,
Hospitals & Clinics, Burn Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 105: Germany Historic Review for Topical Drug Delivery by
End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 106: Germany 15-Year Perspective for Topical Drug
Delivery by End-Use - Percentage Breakdown of Value Sales for
Home Care Settings, Hospitals & Clinics, Burn Centers and Other
End-Uses for the Years 2012, 2021 & 2027

Table 107: Germany Recent Past, Current & Future Analysis for
Topical Drug Delivery by Route Of Administration - Dermal Drug
Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal
Drug Delivery and Vaginal Drug Delivery - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 108: Germany Historic Review for Topical Drug Delivery by
Route Of Administration - Dermal Drug Delivery, Nasal Drug
Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and
Vaginal Drug Delivery Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 109: Germany 15-Year Perspective for Topical Drug
Delivery by Route Of Administration - Percentage Breakdown of
Value Sales for Dermal Drug Delivery, Nasal Drug Delivery,
Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug
Delivery for the Years 2012, 2021 & 2027

ITALY
Table 110: Italy Recent Past, Current & Future Analysis for
Topical Drug Delivery by Product - Semi-Solid Formulations,
Liquid Formulations, Solid Formulations and Transdermal
Products - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 111: Italy Historic Review for Topical Drug Delivery by
Product - Semi-Solid Formulations, Liquid Formulations, Solid
Formulations and Transdermal Products Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 112: Italy 15-Year Perspective for Topical Drug Delivery
by Product - Percentage Breakdown of Value Sales for Semi-Solid
Formulations, Liquid Formulations, Solid Formulations and
Transdermal Products for the Years 2012, 2021 & 2027

Table 113: Italy Recent Past, Current & Future Analysis for
Topical Drug Delivery by End-Use - Home Care Settings,
Hospitals & Clinics, Burn Centers and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 114: Italy Historic Review for Topical Drug Delivery by
End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 115: Italy 15-Year Perspective for Topical Drug Delivery
by End-Use - Percentage Breakdown of Value Sales for Home Care
Settings, Hospitals & Clinics, Burn Centers and Other End-Uses
for the Years 2012, 2021 & 2027

Table 116: Italy Recent Past, Current & Future Analysis for
Topical Drug Delivery by Route Of Administration - Dermal Drug
Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal
Drug Delivery and Vaginal Drug Delivery - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 117: Italy Historic Review for Topical Drug Delivery by
Route Of Administration - Dermal Drug Delivery, Nasal Drug
Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and
Vaginal Drug Delivery Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 118: Italy 15-Year Perspective for Topical Drug Delivery
by Route Of Administration - Percentage Breakdown of Value
Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033143/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001